Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-7,707
Closed -$758K – 2967
2025
Q1
$758K Buy
+7,707
New +$1.03M ﹤0.01% 1262
2024
Q1
– Sell
-14,367
Closed -$1.14M – 2586
2023
Q4
$1.14M Buy
+14,367
New +$980K 0.01% 924
2023
Q3
– Sell
-5,147
Closed -$366K – 2652
2023
Q2
$366K Sell
5,147
-3,348
-39% -$192K ﹤0.01% 1515
2023
Q1
$425K Buy
+8,495
New +$412K 0.01% 1494
2022
Q3
– Sell
-7,749
Closed -$351K – 3060
2022
Q2
$351K Buy
7,749
+2,387
+45% +$113K ﹤0.01% 1910
2022
Q1
$310K Buy
+5,362
New +$284K ﹤0.01% 2208
2021
Q4
– Sell
-17,802
Closed -$857K – 3504
2021
Q3
$857K Buy
17,802
+4,944
+38% +$274K 0.01% 1464
2021
Q2
$1.09M Buy
12,858
+10,128
+371% +$832K 0.01% 973
2021
Q1
$229K Buy
+2,730
New +$240K ﹤0.01% 2248
2019
Q1
– Sell
-5,355
Closed -$300K – 622
2018
Q4
$300K Buy
+5,355
New +$322K 0.04% 349

Other funds holding GKOS

HRT Financial's GKOS Position: Q2 2025 in Review

HRT Financial sold out of Glaukos (GKOS) in Q2 2025, closing a stake of 7,707 shares — an estimated $758K sold.

HRT Financial first reported a position in GKOS in Q4 2018 and held it in 10 quarters. The position peaked at $1.14M in Q4 2023. 297 funds tracked by Wall St. Rank hold GKOS as of Q2 2025.

  • HRT Financial reported no remaining Glaukos position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 7,707 Glaukos shares in Q2 2025, an estimated $758K.
  • HRT Financial first reported a position in Glaukos in Q4 2018 and held it in 10 quarters.
  • HRT Financial's Glaukos position peaked at $1.14M in Q4 2023.
  • 297 funds tracked by Wall St. Rank held Glaukos as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.